Showing results (1991-2000 of 2,058) with videos related to

Sort By:
Pageof 206
Ophthalmology|February 26, 2025
A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with PseudoexfoliationAntonia Kolovos, Ayub Qassim, Mark M Hassall, et al.
Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Ophthalmology. Glaucoma|October 23, 2025
A Multitrait Polygenic Risk Score for Open-Angle Glaucoma Stratifies Risk of Pigmentary Glaucoma in Pigment Dispersion SyndromeAntonia Kolovos, Ayub Qassim, Henry N Marshall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2026
Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear PalsyLouise-Kristine Nielsen, Joshua L I Frost, David P Vaughan, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2015
Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potencyMelissa Egbertson, Georgia B McGaughey, Steven M Pitzenberger, et al.
Science Translational Medicine|April 8, 2020
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in miceTimothy P Sheahan, Amy C Sims, Shuntai Zhou, et al.
Nature Genetics|April 22, 2003
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasiaPamela M Pollock, Karine Cohen-Solal, Raman Sood, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Molecular Cancer Therapeutics|July 19, 2011
Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer modelsMatthew Squires, George Ward, Gordan Saxty, et al.
Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.
Pageof 206